Schedules
Schedules
As of: 1 Sept 2026 source
- 8 weeks: 6-in-1 (Infanrix hexa or Vaxelis); MenB (Bexsero); Rotavirus (Rotarix)
- 12 weeks: 6-in-1; MenB; Rotavirus
- 16 weeks: 6-in-1; PCV (Prevenar 13)
- 1 year: PCV; MenB; MMRV (ProQuad or Priorix-Tetra)
- 18 months (born on/after 1 July 2024): 6-in-1; MMRV
- 3 years 4 months: dTaP/IPV (REPEVAX) (+MMRV for some birth cohorts)
- 12-13 years: HPV (Gardasil 9)
- 14 years: Td/IPV (REVAXIS); MenACWY (MenQuadfi)
- Yearly from age 2 (eligible ages): nasal flu (Fluenz)
- Pregnancy: whooping cough and RSV (Abrysvo) vaccines
- Selective: hep B at birth only if mother has hep B; BCG for higher-risk babies
- Birth (not a vaccine): vitamin K offered (Konakion MM Paediatric)
From July 2025/Jan 2026: Hib/MenC removed; new 18-month appointment; MMR replaced by MMRV (chickenpox added). source
As of: July 2, 2025 schedule, restored after March 16 2026 court ruling (AAP v. Kennedy) source
- Birth: Hep B dose 1; RSV antibody (nirsevimab or clesrovimab) if mother not vaccinated
- 1-2 months: Hep B dose 2
- 2, 4, 6 months: DTaP, Hib, PCV15/PCV20, IPV, Rotavirus (RotaTeq or Rotarix); Hep B dose 3 at 6-18 months
- 6 months+: Flu every year; COVID-19 (shared clinical decision-making)
- 12-15 months: MMR, chickenpox, Hib, PCV boosters; Hep A (2 doses, 12-23 months)
- 15-18 months: DTaP dose 4
- 4-6 years: DTaP, IPV, MMR, chickenpox boosters
- 11-12 years: Tdap, HPV, MenACWY (booster at 16)
- 16-23 years: MenB (shared decision)
- Pregnancy: Tdap; RSV vaccine (Abrysvo) at 32-36 weeks in season
- Birth (not a vaccine): vitamin K injection
Dec 2025 hep B birth-dose change and Jan 2026 schedule reductions were stayed by a federal court; the pre-change schedule is in force as of this writing. Legal status may change. source
How the schedule has changed
At a glance: born in which decade?
Disease doses: each disease a vaccine covers counts as one dose, so a 6-in-1 counts as 6, MMR as 3 and MMRV as 4. Injections are the number of shots. See Definitions.
Guide's own arithmetic, using disease doses (each disease covered counts as 1 dose), injections and diseases from the counts in the tables below. Each decade is represented by one schedule row: UK 1980s = 1983 (reconstruction), 1990s = 1992, 2000s = September 2006, 2010s = 2010, 2020s = January 2020; US 1980s = 1983, 1990s = 1994, 2000s = 2000, 2010s = 2010, 2020s = 2020. 'Born in 2026' = UK schedule from 1 September 2026; US January 2025 schedule (the court restored 'the version as of May 2025', which has the same doses apart from COVID-19). A child's actual schedule depended on the year of birth within the decade, because schedules changed during each decade. Flu and COVID-19 counts use the assumptions stated under 'How this guide counts'.
UK: born in each decade compared with a child born in 2026
Child born in 2026: Sept 2026 (now) schedule source: 48 disease doses (15 injections) for 14 diseases without flu or COVID-19; 62 disease doses (15 injections) for 15 diseases with them.
| Born in | Schedule row used | Without flu or COVID-19 | With flu + COVID-19 |
|---|---|---|---|
| 1980s | 1983 (reconstructed) source | 20 disease doses · 8 injections · 7 diseases vs 2026: 28 more disease doses; 7 more injections; 7 more diseases | 20 disease doses · 8 injections · 7 diseases vs 2026: 42 more disease doses; 7 more injections; 8 more diseases |
| 1990s | 1992 source | 25 disease doses · 11 injections · 9 diseases vs 2026: 23 more disease doses; 4 more injections; 5 more diseases | 25 disease doses · 11 injections · 9 diseases vs 2026: 37 more disease doses; 4 more injections; 6 more diseases |
| 2000s | Sept 2006 source | 35 disease doses · 13 injections · 10 diseases vs 2026: 13 more disease doses; 2 more injections; 4 more diseases | 35 disease doses · 13 injections · 10 diseases vs 2026: 27 more disease doses; 2 more injections; 5 more diseases |
| 2010s | 2010 source | 38 disease doses · 16 injections · 11 diseases vs 2026: 10 more disease doses; 1 fewer injection; 3 more diseases | 38 disease doses · 16 injections · 11 diseases vs 2026: 24 more disease doses; 1 fewer injection; 4 more diseases |
| 2020s | Jan 2020 source | 43 disease doses · 16 injections · 13 diseases vs 2026: 5 more disease doses; 1 fewer injection; 1 more disease | 52 disease doses · 16 injections · 14 diseases vs 2026: 10 more disease doses; 1 fewer injection; 1 more disease |
US: born in each decade compared with a child born in 2026
Child born in 2026: Jan 2025 schedule source: 50 disease doses (31 injections) for 15 diseases without flu or COVID-19; 88 disease doses (69 injections) for 17 diseases with them.
| Born in | Schedule row used | Without flu or COVID-19 | With flu + COVID-19 |
|---|---|---|---|
| 1980s | 1983 source | 24 disease doses · 7 injections · 7 diseases vs 2026: 26 more disease doses; 24 more injections; 8 more diseases | 24 disease doses · 7 injections · 7 diseases vs 2026: 64 more disease doses; 62 more injections; 10 more diseases |
| 1990s | 1994 source | 34 disease doses · 15 injections · 9 diseases vs 2026: 16 more disease doses; 16 more injections; 6 more diseases | 34 disease doses · 15 injections · 9 diseases vs 2026: 54 more disease doses; 54 more injections; 8 more diseases |
| 2000s | 2000 source | 35 disease doses · 20 injections · 10 diseases vs 2026: 15 more disease doses; 11 more injections; 5 more diseases | 35 disease doses · 20 injections · 10 diseases vs 2026: 53 more disease doses; 49 more injections; 7 more diseases |
| 2010s | 2010 source | 50 disease doses · 31 injections · 15 diseases vs 2026: no change in disease doses; no change in injections; no change in diseases | 69 disease doses · 50 injections · 16 diseases vs 2026: 19 more disease doses; 19 more injections; 1 more disease |
| 2020s | 2020 source | 50 disease doses · 31 injections · 15 diseases vs 2026: no change in disease doses; no change in injections; no change in diseases | 69 disease doses · 50 injections · 16 diseases vs 2026: 19 more disease doses; 19 more injections; 1 more disease |
The full routine childhood schedule (birth to 18) at several points in time, in the UK and the US, taken from official schedules or archived copies. Each count below is this guide's own arithmetic from the linked schedule. Full schedules are in the expandable boxes further down.
How this guide counts
- Diseases: each disease named on the schedule counts once. All meningococcal groups (B, C, ACWY) count as one disease, "meningococcal".
- Disease doses (the headline count): each dose is counted once for each disease it covers. A 6-in-1 counts as 6, MMRV as 4, the pre-school 4-in-1 as 4, MMR, DTaP and the teenage 3-in-1 as 3, Hib/MenC as 2, and a single vaccine as 1. This is how the NVIC flyer reaches its totals (see below).
- Injections (shots): doses given by needle. Oral polio, oral rotavirus and the UK nasal flu spray are not injections. Visits means the separate ages listed on that schedule. It does not include yearly flu visits.
- Products given: each time a product is given counts as 1, so a combination counts once. Shown as a secondary column because some widely quoted figures use it.
- Flu and COVID-19 are not in the main columns. They are shown separately, "with flu" and "with flu and COVID-19". US flu is assumed to be 19 doses: one each season from 6 months to 17 years (18 seasons), plus a second dose in the first season. US COVID-19 for January 2025 is assumed to be 19 doses: 2 in the first season (Moderna 2-dose start), then 1 a year. UK flu uses the eligible school years (9 seasons in 2019/20; 14 now). These are the guide's assumptions; the true number depends on birth date and product.
- Where a vaccine was for one sex only (UK rubella in 1983 and 1992; HPV in 2010 in both countries), counts are for a girl.
- Vaccines only for high-risk groups, or left to "shared clinical decision-making", are listed but not counted. The RSV antibody (nirsevimab) is not a vaccine and is not counted.
All counts in this section are the guide's own arithmetic, recalculated by the build script from the linked schedules.
UK counts
| Schedule | Disease doses | Injections | Diseases | Visits | Products given | With flu (disease doses / injections) | With flu + COVID (disease doses / injections) |
|---|---|---|---|---|---|---|---|
| 1983 (reconstructed) reconstruction source | 20 | 8 | 7 | 7 | 13 | no routine child flu | none routine |
| 1992 source | 25 | 11 | 9 | 7 | 16 | no routine child flu | none routine |
| Sept 2006 source | 35 | 13 | 10 | 7 | 13 | no routine child flu | none routine |
| 2010 source | 38 | 16 | 11 | 10 | 16 | no routine child flu | none routine |
| Jan 2020 source | 43 | 16 | 13 | 8 | 18 | 52 / 16 | none routine |
| Jan 2025 source | 42 | 15 | 13 | 7 | 17 | 56 / 15 | none routine |
| Sept 2026 (now) source | 48 | 15 | 14 | 8 | 17 | 62 / 15 | none routine |
UK 2000: no official schedule document was found online. 2006 is the nearest dated official schedule. UK 1983 is the guide's reconstruction (see its box below).
UK: disease doses over time
US counts
| Schedule | Disease doses | Injections | Diseases | Visits | Products given | With flu (disease doses / injections) | With flu + COVID (disease doses / injections) |
|---|---|---|---|---|---|---|---|
| 1983 source | 24 | 7 | 7 | 7 | 11 | no routine child flu | none routine |
| 1989 source | 25 | 8 | 8 | 7 | 12 | no routine child flu | none routine |
| 1994 source | 34 | 15 | 9 | 9 | 19 | no routine child flu | none routine |
| 2000 source | 35 | 20 | 10 | 9 | 20 | no routine child flu | none routine |
| 2010 source | 50 | 31 | 15 | 12 | 34 | 69 / 50 | none routine |
| 2020 source | 50 | 31 | 15 | 12 | 34 | 69 / 50 | none routine |
| Jan 2025 source | 50 | 31 | 15 | 12 | 34 | 69 / 50 | 88 / 69 |
| Jan 2026 (stayed) not in force source | 39 | 23 | 11 | 7 | 23 | 58 / 42 | 77 / 61 |
With combination vaccines, the January 2025 US schedule needs 21 injections instead of 31 (no flu or COVID). How: Vaxelis at 2, 4 and 6 months (replaces 11 single jabs with 3), Quadracel or Kinrix at 4-6 years (2 jabs to 1), ProQuad at 4-6 years (2 jabs to 1). CDC notes say MMR and varicella should be given separately for dose 1 at 12-47 months unless parents prefer MMRV, so ProQuad is not assumed at 12-15 months. source
In force now (22 Oct 2026): CRS reports that the court order of 16 March 2026 put the US schedule back to "the version as of May 2025" source. That version has the same doses as January 2025 except COVID-19. GAP: the guide could not machine-read the COVID-19 category on CDC's live page; check it there. source
US: disease doses over time
routine disease doses yearly flu (assumed) COVID-19 (assumed). Bars show disease doses. Guide's own arithmetic.
Widely quoted figures: which counting method they match
- NVIC's flyer reports "24 DOSES OF 7 VACCINES BY AGE 18" for 1983 and "69 DOSES OF 16 VACCINES BY AGE 18" for 2017 source. 1983: the disease-dose count gives 24 (DTP 5x3 + OPV 4 + MMR 1x3 + Td 1x2). 69: the disease-dose count with flu gives 69 for the 2010 and 2020 schedules (no 2017 schedule was checked).
- A complaint hosted by Children's Health Defense reports a rise "from 11 doses targeting four diseases in 1983, to over 72 doses targeting 18 diseases" source; see also the '72-dose' article. 11 matches the products-given count for 1983. 'Four' matches the number of vaccines in 1983 (DTP, OPV, MMR, Td), not diseases: those vaccines cover 7. 72 matches the products-given count for January 2025 with flu and COVID-19 under this guide's assumptions (34 + 19 + 19). With the RSV antibody, that schedule covers 18 diseases. The complaint does not show its own tally, so the match may be a coincidence.
- "12 in the 80s": matches the products-given count for the 1989 US schedule (DTP 5, OPV 4, MMR 1, Hib 1, Td 1 = 12). source
- "70+ today": matches the products-given count with flu and COVID-19 for January 2025 (72), or the disease-dose count with flu (69). Without flu or COVID-19, the figures are 50 disease doses and 34 products given; with flu and COVID-19, 88 disease doses.
- "30+ after the US cut": for the stayed January 2026 schedule, counting only vaccines for all children: 39 disease doses and 23 products given. So '30+' fits the disease-dose count, not the products-given count. HHS reports that the end-2024 schedule "recommended 17 immunizations for all children" source. CRS reports that 4 of the 19 vaccines on the 2025 schedule were high-risk or shared decision-making only, against 9 of 17 on the 2026 schedule source.
US changes in 2025-2026, as the official record shows them
- May 2025 CDC's child schedule changed after the HHS Secretary's May 2025 COVID-19 directive; the 'version as of May 2025' is the one the court later restored. source
- June 2025 The HHS Secretary terminated the appointments of all sitting ACIP members. source
- 2 July 2025 CDC's live child schedule page shows an addendum dated 2 July 2025. source
- 19 Sept 2025 ACIP recommended COVID-19 vaccination based on individual decision-making. source
- 5 Dec 2025 ACIP recommended individual-based decision-making for the hepatitis B birth dose for infants of mothers who test negative. source
- 5 Jan 2026 The Acting CDC Director adopted a revised schedule: 11 diseases for all children; HPV cut to 1 dose; rotavirus, flu, COVID-19, hepatitis A, hepatitis B, MenACWY, MenB, RSV antibody and dengue moved to high-risk and/or shared clinical decision-making. source
- 16 Mar 2026 The US District Court for Massachusetts (AAP v. Kennedy) stayed the 2026 schedule, reverting it to 'the version as of May 2025', and stayed 13 ACIP appointments and their votes. source
- 29 Apr 2026 The federal government appealed to the First Circuit. source
- 19 May 2026 HHS filed a notice to re-establish ACIP. source
- 29 May 2026 Executive Order 14407 called the 2026 assessment a 'guiding resource' and directed CDC and ACIP to review it. source
- 6 Oct 2026 First Circuit oral argument (news report). No ruling had been reported by 22 Oct 2026. source
Full schedules
UK 1983 (reconstructed) - full schedule
Source: Lang, Loving, McCarthy, Pollard: Two centuries of immunisation in the United Kingdom (Part II), Table 3 (1968, 1992, 2018 schedules) - Oxford University Research Archive · UKHSA: Vaccination timeline table from 1796 to present (updated 20 November 2025)
GAP: No single official 1983 UK schedule was found online. This row is this guide's reconstruction: the 1968 schedule in Lang et al. Table 3 (smallpox removed - routine smallpox vaccination ended in 1971 - and girls' rubella added from the UKHSA timeline). MMR (1988) and the accelerated 2-3-4 month schedule (June 1990) came later.
| Vaccine | Diseases | Doses | Ages | Given as | Notes |
|---|---|---|---|---|---|
| DTP | diphtheria, tetanus, pertussis | 3 | 3 doses from 3-6 months, 6-8 weeks apart | injection | |
| Oral polio | polio | 3 | with DTP | by mouth | |
| Measles | measles | 1 | 2nd year of life | injection | |
| DT + oral polio booster | diphtheria, tetanus | 1 | school entry (about 5 years) | injection | |
| Oral polio booster | polio | 1 | school entry | by mouth | |
| Rubella (girls) | rubella | 1 | 10-14 years | injection | Girls only (rubella programme from 1970, UKHSA timeline). Counts are for a girl. |
| BCG | tuberculosis | 1 | 10-14 years | injection | |
| Tetanus booster | tetanus | 1 | 15-18 years | injection | |
| Oral polio booster | polio | 1 | 15-18 years | by mouth |
Guide's own count: 20 disease doses; 8 injections; 7 diseases; 7 visits (infant 1, infant 2, infant 3, 2nd year, 5y, 10-14y, 15-18y); 13 products given.
UK 1992 - full schedule
Source: Lang, Loving, McCarthy, Pollard: Two centuries of immunisation in the United Kingdom (Part II), Table 3 (1968, 1992, 2018 schedules) - Oxford University Research Archive · UKHSA: Vaccination timeline table from 1796 to present (updated 20 November 2025)
Official UK schedule documents for 2000 were not found online; the next UK row is the September 2006 schedule.
| Vaccine | Diseases | Doses | Ages | Given as | Notes |
|---|---|---|---|---|---|
| DTwP (whole-cell) | diphtheria, tetanus, pertussis | 3 | 2, 3, 4 months | injection | |
| Hib | Hib | 3 | 2, 3, 4 months | injection | Separate injection in 1992 (combined DTwP/Hib from 1996 per UKHSA's 2015 timeline). |
| Oral polio | polio | 3 | 2, 3, 4 months | by mouth | |
| MMR | measles, mumps, rubella | 1 | 12-18 months | injection | |
| DT booster | diphtheria, tetanus | 1 | 4-5 years | injection | |
| Oral polio booster | polio | 1 | 4-5 years | by mouth | |
| Rubella (girls) | rubella | 1 | 10-14 years | injection | Counts are for a girl. |
| BCG | tuberculosis | 1 | 10-14 years | injection | |
| Tetanus booster | tetanus | 1 | 15-18 years | injection | |
| Oral polio booster | polio | 1 | 15-18 years | by mouth |
Guide's own count: 25 disease doses; 11 injections; 9 diseases; 7 visits (2m, 3m, 4m, 12-18m, 4-5y, 10-14y, 15-18y); 16 products given.
UK Sept 2006 - full schedule
BCG had become selective (high-risk infants) and is not in the routine table.
| Vaccine | Diseases | Doses | Ages | Given as | Notes |
|---|---|---|---|---|---|
| DTaP/IPV/Hib (Pediacel) | diphtheria, tetanus, pertussis, polio, Hib | 3 | 2, 3, 4 months | injection | |
| PCV (Prevenar) | pneumococcal | 3 | 2, 4, 13 months | injection | |
| MenC | meningococcal | 2 | 3, 4 months | injection | |
| Hib/MenC (Menitorix) | Hib, meningococcal | 1 | 12 months | injection | |
| MMR | measles, mumps, rubella | 2 | 13 months; 3 years 4 months-5 years | injection | |
| dTaP/IPV pre-school booster | diphtheria, tetanus, pertussis, polio | 1 | 3 years 4 months-5 years | injection | |
| Td/IPV teenage booster | diphtheria, tetanus, polio | 1 | 13-18 years | injection |
Guide's own count: 35 disease doses; 13 injections; 10 diseases; 7 visits (2m, 3m, 4m, 12m, 13m, 3y4m, 13-18y); 13 products given.
UK 2010 - full schedule
Source: Scottish Executive CMO(2006)9: changes to the routine childhood immunisation programme from 4 September 2006 (PDF) · Scottish Government CMO(2008)3: HPV immunisation programme - further guidance (PDF)
The 2006 table plus HPV for girls (2008) and the switch from PCV7 to PCV13 (2010, UKHSA timeline). No routine children's flu programme until 2013 (UKHSA timeline).
| Vaccine | Diseases | Doses | Ages | Given as | Notes |
|---|---|---|---|---|---|
| DTaP/IPV/Hib | diphtheria, tetanus, pertussis, polio, Hib | 3 | 2, 3, 4 months | injection | |
| PCV13 (PCV7 until 2010) | pneumococcal | 3 | 2, 4, 13 months | injection | |
| MenC | meningococcal | 2 | 3, 4 months | injection | |
| Hib/MenC | Hib, meningococcal | 1 | 12 months | injection | |
| MMR | measles, mumps, rubella | 2 | 13 months; 3 years 4 months-5 years | injection | |
| dTaP/IPV pre-school booster | diphtheria, tetanus, pertussis, polio | 1 | 3 years 4 months-5 years | injection | |
| Td/IPV teenage booster | diphtheria, tetanus, polio | 1 | 13-18 years | injection | |
| HPV (girls, Cervarix) | HPV | 3 | 12-13 years, 3 doses within 12 months | injection | Girls only from September 2008 (CMO(2008)3). Counts are for a girl. |
Guide's own count: 38 disease doses; 16 injections; 11 diseases; 10 visits (2m, 3m, 4m, 12m, 13m, 3y4m, 12-13y, HPV 2, HPV 3, 13-18y); 16 products given.
UK Jan 2020 - full schedule
Source: PHE: The routine immunisation schedule from January 2020 (PDF, archived copy)
| Vaccine | Diseases | Doses | Ages | Given as | Notes |
|---|---|---|---|---|---|
| DTaP/IPV/Hib/HepB (Infanrix hexa) | diphtheria, tetanus, pertussis, polio, Hib, hepatitis B | 3 | 8, 12, 16 weeks | injection | |
| MenB (Bexsero) | meningococcal | 3 | 8, 16 weeks; 1 year | injection | |
| Rotavirus (Rotarix, by mouth) | rotavirus | 2 | 8, 12 weeks | by mouth | |
| PCV13 (Prevenar 13) | pneumococcal | 2 | 12 weeks; 1 year | injection | |
| Hib/MenC (Menitorix) | Hib, meningococcal | 1 | 1 year | injection | |
| MMR | measles, mumps, rubella | 2 | 1 year; 3 years 4 months | injection | |
| dTaP/IPV pre-school booster | diphtheria, tetanus, pertussis, polio | 1 | 3 years 4 months | injection | |
| HPV (boys and girls) | HPV | 2 | 12-13 years, 2 doses 6-24 months apart | injection | |
| Td/IPV | diphtheria, tetanus, polio | 1 | 14 years | injection | |
| MenACWY | meningococcal | 1 | 14 years | injection | |
| Flu (yearly) | flu | 9 (assumed) | nasal spray yearly; 2019/20: ages 2-3 and Reception to Year 6 source | nasal spray | Counted only in the 'with flu' / 'with flu and COVID' columns. |
| COVID-19 | COVID-19 | 0 | no COVID-19 vaccine existed | - | Counted only in the 'with flu' / 'with flu and COVID' columns. |
Guide's own count: 43 disease doses; 16 injections; 13 diseases; 8 visits (8w, 12w, 16w, 1y, 3y4m, 12-13y, HPV 2, 14y); 18 products given.
UK Jan 2025 - full schedule
Source: UKHSA: The complete routine immunisation schedule from January 2025 (PDF, archived copy) · UKHSA: The complete routine immunisation schedule (publication page with change history)
| Vaccine | Diseases | Doses | Ages | Given as | Notes |
|---|---|---|---|---|---|
| DTaP/IPV/Hib/HepB (Infanrix hexa or Vaxelis) | diphtheria, tetanus, pertussis, polio, Hib, hepatitis B | 3 | 8, 12, 16 weeks | injection | |
| MenB | meningococcal | 3 | 8, 16 weeks; 1 year | injection | |
| Rotavirus (by mouth) | rotavirus | 2 | 8, 12 weeks | by mouth | |
| PCV13 | pneumococcal | 2 | 12 weeks; 1 year | injection | |
| Hib/MenC | Hib, meningococcal | 1 | 1 year | injection | |
| MMR | measles, mumps, rubella | 2 | 1 year; 3 years 4 months | injection | |
| dTaP/IPV (REPEVAX) | diphtheria, tetanus, pertussis, polio | 1 | 3 years 4 months | injection | |
| HPV (Gardasil 9) | HPV | 1 | 12-13 years, 1 dose (from September 2023) | injection | One dose for most young people; 3 for immunocompromised (schedule footnote). |
| Td/IPV | diphtheria, tetanus, polio | 1 | 14 years | injection | |
| MenACWY | meningococcal | 1 | 14 years | injection | |
| Flu (yearly) | flu | 14 (assumed) | nasal spray yearly: ages 2-3 and Reception to Year 11 source | nasal spray | Counted only in the 'with flu' / 'with flu and COVID' columns. |
| COVID-19 | COVID-19 | 0 | not offered to healthy children (JCVI) source | - | Counted only in the 'with flu' / 'with flu and COVID' columns. |
Guide's own count: 42 disease doses; 15 injections; 13 diseases; 7 visits (8w, 12w, 16w, 1y, 3y4m, 12-13y, 14y); 17 products given.
UK Sept 2026 (now) - full schedule
Source: UKHSA: The complete routine immunisation schedule from 1 September 2026 (PDF) · UKHSA: The complete routine immunisation schedule (publication page with change history)
For a child born on or after 1 July 2024 (18-month visit) and on or after 1 January 2025 (no MMRV at 3 years 4 months). Hib/MenC at 1 year was removed from 1 January 2026; MMRV and the 18-month 6-in-1 dose were added (UKHSA change history).
| Vaccine | Diseases | Doses | Ages | Given as | Notes |
|---|---|---|---|---|---|
| DTaP/IPV/Hib/HepB (6-in-1) | diphtheria, tetanus, pertussis, polio, Hib, hepatitis B | 4 | 8, 12, 16 weeks; 18 months | injection | |
| MenB (Bexsero) | meningococcal | 3 | 8, 12 weeks; 1 year | injection | |
| Rotavirus (Rotarix, by mouth) | rotavirus | 2 | 8, 12 weeks | by mouth | |
| PCV (Prevenar 13) | pneumococcal | 2 | 16 weeks; 1 year | injection | |
| MMRV (ProQuad or Priorix Tetra) | measles, mumps, rubella, chickenpox | 2 | 1 year; 18 months | injection | |
| dTaP/IPV (REPEVAX) | diphtheria, tetanus, pertussis, polio | 1 | 3 years 4 months | injection | |
| HPV (Gardasil 9) | HPV | 1 | 12-13 years | injection | |
| Td/IPV (REVAXIS) | diphtheria, tetanus, polio | 1 | 14 years | injection | |
| MenACWY (MenQuadfi) | meningococcal | 1 | 14 years | injection | |
| Flu (yearly) | flu | 14 (assumed) | nasal spray yearly: ages 2-3 and Reception to Year 11 source | nasal spray | Counted only in the 'with flu' / 'with flu and COVID' columns. |
| COVID-19 | COVID-19 | 0 | not offered to healthy children (JCVI) source | - | Counted only in the 'with flu' / 'with flu and COVID' columns. |
Guide's own count: 48 disease doses; 15 injections; 14 diseases; 8 visits (8w, 12w, 16w, 1y, 18m, 3y4m, 12-13y, 14y); 17 products given.
US 1983 - full schedule
Source: CDC archive: 1983 childhood immunization schedule (ACIP, Table 1) · CDC: Past immunization schedules (archive page, 1983 onwards)
| Vaccine | Diseases | Doses | Ages | Given as | Notes |
|---|---|---|---|---|---|
| DTP | diphtheria, tetanus, pertussis | 5 | 2, 4, 6, 18 months; 4-6 years | injection | |
| OPV (oral polio) | polio | 4 | 2, 4, 18 months; 4-6 years | by mouth | A 6-month dose was optional in high-risk areas (not counted). |
| MMR | measles, mumps, rubella | 1 | 15 months | injection | |
| Td | diphtheria, tetanus | 1 | 14-16 years | injection |
Guide's own count: 24 disease doses; 7 injections; 7 diseases; 7 visits (2m, 4m, 6m, 15m, 18m, 4-6y, 14-16y); 11 products given.
US 1989 - full schedule
Source: CDC archive: 1989 childhood immunization schedule (ACIP, Table 2) · CDC: Past immunization schedules (archive page, 1983 onwards)
| Vaccine | Diseases | Doses | Ages | Given as | Notes |
|---|---|---|---|---|---|
| DTP | diphtheria, tetanus, pertussis | 5 | 2, 4, 6, 15 months; 4-6 years | injection | |
| OPV (oral polio) | polio | 4 | 2, 4, 15 months; 4-6 years | by mouth | |
| MMR | measles, mumps, rubella | 1 | 15 months | injection | |
| HbCV (Hib conjugate) | Hib | 1 | 18 months | injection | |
| Td | diphtheria, tetanus | 1 | 14-16 years | injection |
Guide's own count: 25 disease doses; 8 injections; 8 diseases; 7 visits (2m, 4m, 6m, 15m, 18m, 4-6y, 14-16y); 12 products given.
US 1994 - full schedule
Source: CDC archive: 1994 childhood immunization schedule (Table 3, birth to 4-6 years) · CDC: Past immunization schedules (archive page, 1983 onwards)
The 1994 table stops at school entry (4-6 years); a DTP/Hib combination (TETRAMUNE) is listed in its footnotes.
| Vaccine | Diseases | Doses | Ages | Given as | Notes |
|---|---|---|---|---|---|
| Hepatitis B | hepatitis B | 3 | birth; 1-2 months; 6-18 months (option 1) | injection | |
| DTP / DTaP | diphtheria, tetanus, pertussis | 5 | 2, 4, 6, 15 months; 4-6 years | injection | |
| OPV (oral polio) | polio | 4 | 2, 4, 6-18 months; 4-6 years | by mouth | |
| Hib (HbOC or PRP-T) | Hib | 4 | 2, 4, 6, 12-15 months | injection | 3 doses if PRP-OMP (PedvaxHIB) is used. |
| MMR | measles, mumps, rubella | 2 | 12-15 months; 4-6 years (AAP: 11-12 years) | injection | |
| Td | diphtheria, tetanus | 1 | 11-16 years | injection | NOT in the 1994 table (which ends at 4-6 years). Included by this guide because the 1989 and 2000 CDC schedules both list it; treat as an assumption. |
Guide's own count: 34 disease doses; 15 injections; 9 diseases; 9 visits (birth, 1-2m, 2m, 4m, 6m, 12-15m, 15m, 4-6y, 11-16y); 19 products given.
US 2000 - full schedule
Source: CDC MMWR 49(02): Recommended Childhood Immunization Schedule - United States, 2000
Hepatitis A was for selected areas only (not counted). Rotavirus vaccine had been withdrawn in 1999.
| Vaccine | Diseases | Doses | Ages | Given as | Notes |
|---|---|---|---|---|---|
| Hepatitis B | hepatitis B | 3 | birth-2 months; 1-4 months; 6-18 months | injection | |
| DTaP | diphtheria, tetanus, pertussis | 5 | 2, 4, 6, 15-18 months; 4-6 years | injection | |
| Td | diphtheria, tetanus | 1 | 11-12 years | injection | |
| Hib | Hib | 4 | 2, 4, 6, 12-15 months | injection | 3 doses if PRP-OMP is used. |
| IPV (injected polio) | polio | 4 | 2, 4, 6-18 months; 4-6 years | injection | |
| MMR | measles, mumps, rubella | 2 | 12-15 months; 4-6 years | injection | |
| Varicella | chickenpox | 1 | 12-18 months | injection |
Guide's own count: 35 disease doses; 20 injections; 10 diseases; 9 visits (birth, 1-2m, 2m, 4m, 6m, 12-15m, 15-18m, 4-6y, 11-12y); 20 products given.
US 2010 - full schedule
| Vaccine | Diseases | Doses | Ages | Given as | Notes |
|---|---|---|---|---|---|
| Hepatitis B | hepatitis B | 3 | birth; 1-2 months; 6-18 months | injection | |
| Rotavirus (oral) | rotavirus | 3 | 2, 4, 6 months | by mouth | RV5 = 3 doses; RV1 = 2 doses. |
| DTaP | diphtheria, tetanus, pertussis | 5 | 2, 4, 6, 15-18 months; 4-6 years | injection | |
| Hib | Hib | 4 | 2, 4, 6, 12-15 months | injection | 3 doses if PRP-OMP. |
| Pneumococcal conjugate (PCV) | pneumococcal | 4 | 2, 4, 6, 12-15 months | injection | |
| IPV | polio | 4 | 2, 4, 6-18 months; 4-6 years | injection | |
| MMR | measles, mumps, rubella | 2 | 12-15 months; 4-6 years | injection | |
| Varicella | chickenpox | 2 | 12-15 months; 4-6 years | injection | |
| Hepatitis A | hepatitis A | 2 | 12-23 months (2 doses) | injection | |
| Tdap | diphtheria, tetanus, pertussis | 1 | 11-12 years | injection | |
| HPV (girls) | HPV | 3 | 11-12 years, 3-dose series | injection | Routine for girls; for boys 'may be given' (permissive). Counts are for a girl. |
| MCV4 (meningococcal) | meningococcal | 1 | 11-12 years | injection | |
| Flu (yearly) | flu | 19 (assumed) | yearly, 6 months to 18 years | injection | Counted only in the 'with flu' / 'with flu and COVID' columns. |
Guide's own count: 50 disease doses; 31 injections; 15 diseases; 12 visits (birth, 1-2m, 2m, 4m, 6m, 12-15m, 15-18m, 18-23m, 4-6y, 11-12y, HPV 2, HPV 3); 34 products given.
US 2020 - full schedule
Source: CDC: Recommended Child and Adolescent Immunization Schedule, United States, 2020 (PDF)
| Vaccine | Diseases | Doses | Ages | Given as | Notes |
|---|---|---|---|---|---|
| Hepatitis B | hepatitis B | 3 | birth; 1-2 months; 6-18 months | injection | |
| Rotavirus (oral) | rotavirus | 3 | 2, 4, 6 months | by mouth | RV5 = 3 doses; RV1 = 2 doses. |
| DTaP | diphtheria, tetanus, pertussis | 5 | 2, 4, 6, 15-18 months; 4-6 years | injection | |
| Hib | Hib | 4 | 2, 4, 6, 12-15 months | injection | 3 doses if PedvaxHIB. |
| PCV13 | pneumococcal | 4 | 2, 4, 6, 12-15 months | injection | |
| IPV | polio | 4 | 2, 4, 6-18 months; 4-6 years | injection | |
| MMR | measles, mumps, rubella | 2 | 12-15 months; 4-6 years | injection | |
| Varicella | chickenpox | 2 | 12-15 months; 4-6 years | injection | |
| Hepatitis A | hepatitis A | 2 | 12-23 months | injection | |
| Tdap | diphtheria, tetanus, pertussis | 1 | 11-12 years | injection | |
| HPV | HPV | 2 | 11-12 years (2 doses if started before 15) | injection | |
| MenACWY | meningococcal | 2 | 11-12 years; 16 years | injection | |
| Flu (yearly) | flu | 19 (assumed) | yearly from 6 months | injection | Counted only in the 'with flu' / 'with flu and COVID' columns. |
- MenB at 16-18 years: shared clinical decision-making (not counted).
Guide's own count: 50 disease doses; 31 injections; 15 diseases; 12 visits (birth, 1-2m, 2m, 4m, 6m, 12-15m, 15-18m, 18-23m, 4-6y, 11-12y, HPV 2, 16y); 34 products given.
US Jan 2025 - full schedule
| Vaccine | Diseases | Doses | Ages | Given as | Notes |
|---|---|---|---|---|---|
| Hepatitis B | hepatitis B | 3 | birth; 1-2 months; 6-18 months | injection | |
| Rotavirus (oral) | rotavirus | 3 | 2, 4, 6 months | by mouth | RV5 = 3 doses; RV1 = 2 doses. |
| DTaP | diphtheria, tetanus, pertussis | 5 | 2, 4, 6, 15-18 months; 4-6 years | injection | |
| Hib | Hib | 4 | 2, 4, 6, 12-15 months | injection | 3 doses if PedvaxHIB. |
| PCV15 / PCV20 | pneumococcal | 4 | 2, 4, 6, 12-15 months | injection | |
| IPV | polio | 4 | 2, 4, 6-18 months; 4-6 years | injection | |
| MMR | measles, mumps, rubella | 2 | 12-15 months; 4-6 years | injection | |
| Varicella | chickenpox | 2 | 12-15 months; 4-6 years | injection | |
| Hepatitis A | hepatitis A | 2 | 12-23 months | injection | |
| Tdap | diphtheria, tetanus, pertussis | 1 | 11-12 years | injection | |
| HPV | HPV | 2 | 11-12 years (can start at 9) | injection | |
| MenACWY | meningococcal | 2 | 11-12 years; 16 years | injection | |
| Flu (yearly) | flu | 19 (assumed) | yearly from 6 months | injection | Counted only in the 'with flu' / 'with flu and COVID' columns. |
| COVID-19 | COVID-19 | 19 (assumed) | from 6 months; routine for all ages in the Jan 2025 edition | injection | Counted only in the 'with flu' / 'with flu and COVID' columns. |
- RSV monoclonal antibody (nirsevimab or clesrovimab): 1 dose under 8 months if the mother was not vaccinated - an antibody, not a vaccine; listed separately, not counted.
- MenB at 16-18 years: shared clinical decision-making (not counted). Dengue: only for children with lab-confirmed past infection in endemic areas (not counted).
Guide's own count: 50 disease doses; 31 injections; 15 diseases; 12 visits (birth, 1-2m, 2m, 4m, 6m, 12-15m, 15-18m, 18-23m, 4-6y, 11-12y, HPV 2, 16y); 34 products given.
US Jan 2026 (stayed) - full schedule
Source: HHS: Fact Sheet - CDC Childhood Immunization Recommendations (5 January 2026) · Congressional Research Service R48982: The 2026 Childhood Immunization Schedule (11 June 2026)
Status: Stayed by the US District Court for Massachusetts on 16 March 2026 (CRS R48982); not in force as of 22 Oct 2026.
Counts show the doses recommended for ALL children on this schedule. The doses moved to high-risk / shared decision-making are not counted in the main figures.
| Vaccine | Diseases | Doses | Ages | Given as | Notes |
|---|---|---|---|---|---|
| DTaP | diphtheria, tetanus, pertussis | 5 | 2, 4, 6, 15-18 months; 4-6 years | injection | |
| Tdap | diphtheria, tetanus, pertussis | 1 | 11-12 years | injection | |
| IPV | polio | 4 | 2, 4, 6-18 months; 4-6 years | injection | |
| Hib | Hib | 4 | 2, 4, 6, 12-15 months | injection | Dose timing not changed by the 2026 memo (CRS: 'mostly remain as they were'). |
| PCV | pneumococcal | 4 | 2, 4, 6, 12-15 months | injection | |
| MMR | measles, mumps, rubella | 2 | 12-15 months; 4-6 years | injection | |
| Varicella | chickenpox | 2 | 12-15 months; 4-6 years | injection | |
| HPV | HPV | 1 | 1 dose (was 2) | injection | |
| Flu (yearly) | flu | 19 (assumed) | moved to shared clinical decision-making | injection | Counted only in the 'with flu' / 'with flu and COVID' columns. |
| COVID-19 | COVID-19 | 19 (assumed) | individual decision-making (ACIP, 19 Sept 2025) | injection | Counted only in the 'with flu' / 'with flu and COVID' columns. |
- Moved to high-risk groups and/or shared clinical decision-making: hepatitis B (for infants of mothers who test negative), hepatitis A, MenACWY, MenB, RSV antibody, dengue; rotavirus, flu and COVID-19 moved to shared clinical decision-making only (HHS fact sheet; CRS R48982).
Guide's own count: 39 disease doses; 23 injections; 11 diseases; 7 visits (2m, 4m, 6m, 12-15m, 15-18m, 4-6y, 11-12y); 23 products given.
What's coming, visit by visit (child born now)
For a child born on 22 October 2026, from the schedules in force. Each vaccine links to its ingredient entry in this guide; that entry links to the official leaflet.
UK (schedule from 1 September 2026)
source| Age | Vaccines and doses offered (disease doses each) | Disease doses at this visit | Injections at this visit |
|---|---|---|---|
| 8 weeks | 8 | 2 | |
| 12 weeks | 8 | 2 | |
| 16 weeks |
| 7 | 2 |
| 1 year |
| 6 | 3 |
| 18 months |
| 10 | 2 |
| 2-3 years, then Reception to Year 11 (each autumn) | 1 a year | 0 (nasal) | |
| 3 years 4 months | 4 | 1 | |
| 12-13 years (school Year 8) |
| 1 | 1 |
| 14 years (school Year 9) |
| 4 | 2 |
Guide's own total at the routine visits: 48 disease doses and 15 injections (the disease doses include 2 rotavirus doses by mouth), plus about 14 yearly nasal flu sprays (14 more disease doses, no injections).
Babies at higher risk may also be offered hepatitis B at birth and 4 weeks, BCG, or injected flu (selective programmes on the same UKHSA schedule). Brand shown: the 6-in-1 may be Infanrix hexa or Vaxelis; MMRV may be ProQuad or Priorix Tetra.
Consent: the Scottish Government reports that "Vaccinations are not compulsory" source. The UKHSA Green Book reports that, to be valid, consent "must be given freely, voluntarily and without coercion" source.
US (CDC schedule as restored by the March 2026 court order)
source live page| Age | Vaccines and doses offered (disease doses each) | Disease doses at this visit | Injections at this visit |
|---|---|---|---|
| Birth | 2 | 2 | |
| 1-2 months | 1 | 1 | |
| 2 months |
| 7 | 4 |
| 4 months |
| 7 | 4 |
| 6 months | 8 | 5 | |
| 6 months, then every autumn | 2 a year | 2 a year | |
| 12-15 months | 7 | 5 | |
| 15-18 months |
| 3 | 1 |
| 18-23 months | 1 | 1 | |
| 4-6 years |
| 8 | 4 |
| 11-12 years | 5 | 3 | |
| 16 years | 2 | 2 |
Guide's own total at the routine visits listed: 51 disease doses and 32 injections (counting the RSV antibody, MenB and HPV dose 1 as listed; HPV dose 2 comes 6-12 months later), plus yearly flu and any COVID-19 doses. Combination vaccines cut the injections, not the disease doses; see the US counts above.
Hepatitis B doses 3 and IPV dose 3 may be given at any visit from 6 to 18 months; injection counts assume 6 months. COVID-19: the January 2025 edition recommended it for everyone from 6 months; ACIP moved it to individual decision-making on 19 Sept 2025 source, but the court stayed votes by the newly appointed ACIP members source. GAP: the category now shown for COVID-19 on CDC's live page was not verified by this guide. If the stayed January 2026 schedule takes effect, rotavirus, flu, COVID-19, hepatitis A, hepatitis B (mother negative), MenACWY and the RSV antibody move to high-risk and/or shared decision-making, and HPV becomes 1 dose source.
School exemptions by state: NCSL reports that all 50 states and DC require certain vaccines for school and all allow medical exemptions. 29 states and DC allow religious exemptions only; 16 states allow religious or personal-belief exemptions; Minnesota allows personal (conscientious) exemptions; 4 states (California, Connecticut, Maine, New York) allow no non-medical exemption source.
State-by-state exemption rules (NCSL, updated 1 Sept 2026)
Religious exemption only (29 states + DC): Alabama, Alaska, Delaware, District of Columbia, Florida, Georgia, Hawaii, Illinois, Indiana, Iowa, Kansas, Kentucky, Maryland, Massachusetts, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, North Carolina, Rhode Island, South Carolina, South Dakota, Tennessee, Vermont, Virginia, Wyoming. DC and Virginia also allow a personal exemption for HPV only.
Religious or personal-belief exemption (16): Arizona, Arkansas, Colorado, Idaho, Louisiana, Michigan, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Texas, Utah, Washington, West Virginia, Wisconsin. In Louisiana an exemption is by written dissent, with no reason in statute. In West Virginia exemptions are on hold while the state Supreme Court considers the case. Washington removed the personal-belief exemption for MMR in 2019.
Personal only: Minnesota (notarised statement). No non-medical exemption: California (removed 2015), Connecticut (2021), Maine (2019), New York (2019).
NCSL's page links each state's statute NCSL state law links.